Stem cells after myocardial infarction;Stammzellen nach myokardinfarkt

Herz

Volumn 31, Issue 2, 2006, Pages 127-136

  Schächinger, Volker ^a   Dimmeler, Stefanie ^b   Zeiher, Andreas M ^a  

^a GOETHE UNIVERSITY   (Germany)

^b JW Goethe Universität Frankfurt ^*

Author keywords

Coronary artery disease; Heart failure; Myocardial infarction; Stem cells

Indexed keywords

ARTICLE; CLINICAL FEATURE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HUMAN; RANDOMIZATION; STEM CELL; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; CELL DIFFERENTIATION; DOUBLE-BLIND METHOD; FEASIBILITY STUDIES; FEMALE; FORECASTING; HUMANS; MALE; MULTICENTER STUDIES; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SAFETY; STEM CELL TRANSPLANTATION; STEM CELLS; VENTRICULAR FUNCTION, LEFT;

EID: 33745181670     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2794-x     Document Type: Article

References (54)

1. Aicher A, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003;9:1370-6.
2. Asahara T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
3. Assmus B, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002;106:3009-17.
4. Badorff C, et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003;107:1024-32.
5. Balsam LB, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-73.
6. Bartunek J, et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005;112:I178-83.
7. Beltrami AP, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114: 763-76.
8. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell 2001;105:829-41.
9. Britten MB, et al. Infarct remodeling after intracoronary progenitor cell treatment inpatients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003;108:2212-8.
10. Chen SL, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-5.
11. Deb A, et al. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mis-matched bone marrow transplantation patients. Circulation 2003;107:1247-9.
12. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572-83.
13. Engelhardt M, et al. Plastizität adulter Stammzellen: Wunschtraum oder Realität? Dtsch Ärztebl 2003;100:A3236-44.
14. Erbs S, et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 2005;97:756-62.
15. Fernandez-Aviles F, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004;95:742-8.
16. Heeschen C, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109:1615-22.
17. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood 2003;102:3483-93.
18. Hill JM, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:593-600.
19. Hill JM, et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1643-8.
20. Hofmann M, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005;111: 2198-202.
21. Ince H, et al. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) trial. Circulation 2005;112: I73-80.
22. Iten LB. Forelimb regeneration from different levels of amputation in the newt N. viridescens. Length, rate and stages. Wilhelm Roux Arch Dev Biol 1973;173:263-82.
23. Jackson KA, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-402.
24. Janssens S, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction:double-blind, randomised controlled trial. Lancet 2006;367:113-21.
25. Kang HJ, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-6.
26. Kawamoto A, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634-7.
27. Lunde K, et al. Effects on left ventricular function by intracoronary injections of autologous mononuclear bone marrow cells in acute anterior wall myocardial infarction: the ASTAMI randomized controlled trial, 16-11-2005 [Internet Communication] (http://scientificsessions.americanheart. org/portal/scientificsession/ss/lbctnewsrelease14).
28. Muller P, et al. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation 2002;106:31-5.
29. Murry CE, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
30. Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005;112: 3174-83.
31. Nygren JM, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004;10: 494-501.
32. Orlic D, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
33. Orlic D, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001;98:10344-9.
34. Parmacek MS, Epstein JA. Pursuing cardiac progenitors: regeneration redux. Cell 2005;120:295-8.
35. Quaini F, et al. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15.
36. Reddien PW, et al. Identification of genes needed for regeneration, stem cell function, and tissue homeostasis by systematic gene perturbation in planaria. Dev Cell 2005;8:635-49.
37. Ruan W, et al. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chin Med J (Engl) 2005;118:1175-81.
38. Sandri M, et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies.Circulation 2005;111:3391-9.
39. Schächinger V, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 2004;44:1690-9.
40. Schächinger S, et al. Intracoronary infusion of bone marrow-derived progenitor cells in acute myocardial infarction: a randomized, double-blind, placebo-controlled multicenter trial (REPAIR-AMI), 13-11-2005 [Internet Communcation] (http://scientificsessions.americanheart.org/portal/sdentif- icsessions/ss/lbctnewsrelease1).
41. Schächinger V, et al. Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial. Clin Res Cardiol 2006;95:13-22.
42. Schächinger V, et al. Bone marrow-derived progenitor cell therapy in need of proof-of-concept: design of the RE-PAIR-AMI trial. Nat Clin Pract Cardiovasc Med 2006;33: Suppl 1:523-8.
43. Schächinger V, Zeiher AM. Koronare Mikrozirkulation: Pathophysiologie, klinische Beurteilung und Bedeutung für regenerative Therapie nach Myokardinfarkt. Herz 2005; 30:641-50.
44. Schmidt-Lucke C, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.Circulation 2005;111:2981-7.
45. Strauer BE, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.Circulation 2002;106:1913-8.
46. Takahashi T, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-8.
47. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-53.
48. Urbich C, et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003;108:2511-6.
49. Vasa M, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;189:Ei-7.
50. Walter DH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002;105:3017-24.
51. Wang Y, Tägil K, Ripa RS, et al. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol 2005;100:477-83.
52. Werner N, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003;93:617-24.
53. Werner N, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007.
54. Wollert KC, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-8.